LouisBChaykinMD

Endocrinology • Sarasota, FL

Diabetes

Physician

Join to view full profile

Dr. Chaykin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Chaykin's full profile

Already have an account?

Office
1900 Brother Geenen Way
Sarasota, FL 34236
Phone+1 941-556-3220

Fax+1 941-955-8214
Is this information wrong?

Education & Training

University of Pennsylvania Health SystemResidency, Internal Medicine, 1964 - 1965
University of Pennsylvania Health SystemResidency, Internal Medicine, 1962 - 1964
Mercy Catholic Medical CenterInternship, Transitional Year, 1961 - 1962
Lewis Katz School of Medicine at Temple UniversityClass of 1961

Certifications & Licensure

PA State Medical License 1962 - Present
FL State Medical License 1973 - 2025
TN State Medical License 1981 - 1995
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

A Study to Determine the Effects of TM30339 on Weight Loss in Obese Individuals. Start of enrollment: 2008 Aug 01
Terminated
Phase 2
The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN) Start of enrollment: 2013 Nov 01
Unknown status
Not Applicable
A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes Start of enrollment: 2014 Apr 01
Completed
Phase 2
12-Week Study of Plecanatide for CIC (The National CIC3 Study) Start of enrollment: 2014 Apr 01
Completed
Phase 3
Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM Start of enrollment: 2015 Oct 01
Completed
Phase 2
A 12-Week Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia Start of enrollment: 2016 Dec 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

14 citations
Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: A patient-level, pooled analysis of the S...
Vanita R. Aroda, Matthew Capehorn, Louis Chaykin, Juan P. Frias, Nanna L. Lausvig, Stanislava Macura, Jörg Lüdemann, Sten Madsbad, Julio Rosenstock, Omur Tabak, Sayeh ...> ;Diabetes, Obesity & Metabolism. 2020 Mar 1
1 citations
Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patient...
Mark Warren, Meryl Brod, Jonas Håkan-Bloch, Thomas Sparre, Louis Chaykin> ;Current Medical Research and Opinion. 2019 May 21
2 citations
Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial.
Louis B. Chaykin, Anuj Bhargava, Raymond de la Rosa, Carol Wysham, Lone Nørgård Troelsen, Signe H. Østoft, Athena Philis-Tsimikas> ;Clinical Diabetes. 2019 Jan 1
32 citations
Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trials.
Mark Warren, Louis Chaykin, David E. Trachtenbarg, Gurudutt Nayak, Nelun Wijayasinghe, Bertrand Cariou> ;Diabetes, Obesity & Metabolism. 2018 Sep 1
167 citations
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
Carol Wysham, Anuj Bhargava, Louis B. Chaykin, Raymond de la Rosa, Yehuda Handelsman, Lone Nørgård Troelsen, Kajsa Kvist, Paul Norwood> ;JAMA. 2017 Jul 4
15 citations
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patien...
Mark Warren, Louis Chaykin, Serge Jabbour, Mae Sheikh-Ali, Charlotte T. Hansen, Thor S. S. Nielsen, Paul Norwood> ;Clinical Diabetes. 2017 Apr 1
5 citations
Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal–Bolus): Exploratory Randomized Trial in Type 2 Diabetes
Wan Mohamaed Wan Bebakar, Louis Chaykin, Malene Lundgren Hersløv, Søren Rasmussen> ;Diabetes Therapy. 2017 Feb 1
95 citations
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Thera...
Sultan Linjawi, Bruce W. Bode, Louis B. Chaykin, J.-P. Courreges, Yehuda Handelsman, Lucine Lehmann, Abhishek Mishra, Richard W Simpson> ;Diabetes Therapy. 2017 Feb 1
21 citations
Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Patients with Type 2 Diabetes (Begin: Compare)
Bruce W. Bode, Louis Chaykin, Allen M Sussman, Mark Warren, Marcus Niemeyer, Rasmus Rabøl, Helena W. Rodbard> ;Endocrine Practice. 2014 Aug 1
96 citations
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes.
Philip Raskin, Titus Gylvin, Wayne Weng, Louis Chaykin> ;Diabetes/metabolism Research and Reviews. 2009 Sep 1
Addition of biphasic insulin aspart 30 to optimized metformin and pioglitazone treatment of type 2 diabetes mellitus: The ACTION Study (Achieving Control Through Insul...
Raskin P, Matfin G, Schwartz SL, Chaykin L, Chu P, Braceras R, Wynne A> ;Diabetes Obes Metab. 2009-01-01
9 citations
Spondylitis of hypoparathyroidism.
Carlina V. Jimenea, Louis B. Chaykin, John W. Sigler> ;Clinical Orthopaedics and Related Research. 1971 Jan 1
13 citations
Spondylitis: A Clue to Hypoparathyroidism
Louis B. Chaykin, Boy Frame, John W. Sigler> ;Annals of Internal Medicine. 1969 May 1
8 citations
Maternal hyperparathyroidism and pregnancy.
Alan Rubin, Louis B. Chaykin, George D. Ludwig> ;JAMA. 1968 Sep 30
71 citations
Incomplete renal tubular acidosis: Physiologic studies in three patients with a defect in lowering urine pH
Vardaman M. Buckalew, Donna K. McCurdy, George D. Ludwig, Louis B. Chaykin, J. Russell Elkinton> ;The American Journal of Medicine. 1968 Jul 1
4 citations
Cerebral Gigantism with Intermittent Fractional Hypopituitarism and Normal Sella Turcica
George D. Ludwig, Louis B. Chaykin, Antonio V. Escueta> ;Annals of Internal Medicine. 1967 Jul 1
Double-blind clinical evaluation of mazindol, dextroamphetamine, and placebo in treatment of exogenous obesity.
Defelice, E. A., Chaykin, L. B., Cohen, A.> ;Curr Ther Res Clin Exp. 1973 Jul 01
Join now to see all